Parham Sendi
Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial.
Urwyler P, Leimbacher M, Charitos P, Moser S, Fehrman-Ekholm I, Trendelenburg M, Thoma R, Sumer J, Camacho-Ortiz A, Bacci M, Huber L, Stüssi-Helbling M, Albrich W, Sendi P, Osthoff M. Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial. Front Immunol 2023; 14:1255292.
27.10.2023Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial.
27.10.2023Front Immunol 2023; 14:1255292
Urwyler Pascal, Leimbacher Marina, Charitos Panteleimon, Moser Stephan, Fehrman-Ekholm Ingela, Trendelenburg Marten, Thoma Reto, Sumer Johannes, Camacho-Ortiz Adrián, Bacci Marcelo R, Huber Lars Chistian, Stüssi-Helbling Melina, Albrich Werner, Sendi Parham, Osthoff Michael
Infective endocarditis: prevention and antibiotic prophylaxis
Sendi P, Knirsch W, Agyeman P, Zbinden S, Jeger R, Guery B, Boggian K, Fluckiger U, Frank M, Hasse B, Greutmann M. Infective endocarditis: prevention and antibiotic prophylaxis. Swiss Med Wkly 2021; 151:w20473.
28.02.2021Infective endocarditis: prevention and antibiotic prophylaxis
28.02.2021Swiss Med Wkly 2021; 151:w20473
Sendi Parham, Knirsch Walter, Agyeman Philipp, Zbinden Stephan, Jeger Raban, Guery Benoit, Boggian Katia, Fluckiger Ursula, Frank Michelle, Hasse Barbara, Greutmann Matthias
The Impact of Surgical Strategy and Rifampin on Treatment Outcome in Cutibacterium Periprosthetic Joint Infections
Kusejko K, Ferrari M, Gassmann N, Sendi P, Jent P, Morand P, Vijayvargiya P, Trebše R, Patel R, Kouyos R, Corvec S, Kramer T, Stadelmann V, Wouthuyzen-Bakker M, Fernandez-Sampedro M, Clauss M, Auñón Á, Jost B, Benito N, Strahm C, Thurnheer C, Pablo-Marcos D, Slama D, Scanferla G, Uçkay I, Waldmann I, Esteban J, Lora-Tamayo J, Achermann Y. The Impact of Surgical Strategy and Rifampin on Treatment Outcome in Cutibacterium Periprosthetic Joint Infections. Clin Infect Dis 2021; 72:e1064-e1073.
15.01.2021The Impact of Surgical Strategy and Rifampin on Treatment Outcome in Cutibacterium Periprosthetic Joint Infections
15.01.2021Clin Infect Dis 2021; 72:e1064-e1073
Kusejko Katharina, Ferrari Matteo Carlo, Gassmann Natalie, Sendi Parham, Jent Philipp, Morand Philippe C, Vijayvargiya Prakhar, Trebše Rihard, Patel Robin, Kouyos Roger D, Corvec Stéphane, Kramer Tobias Siegfried, Stadelmann Vincent A, Wouthuyzen-Bakker Marjan, Fernandez-Sampedro Marta, Clauss Martin, Auñón Álvaro, Jost Bernhard, Benito Natividad, Strahm Carol, Thurnheer Christine, Pablo-Marcos Daniel, Slama Dorsaf, Scanferla Giulia, Uçkay Ilker, Waldmann Isabelle, Esteban Jaime, Lora-Tamayo Jaime, Achermann Yvonne
Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19)
Urwyler P, Sendi P, Albrich W, Stüssi-Helbling M, Huber L, Bacci M, Camacho-Ortiz A, Sumer J, Thoma R, Trendelenburg M, Heijnen I, Moser S, Charitos P, Osthoff M. Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19). Trials 2021; 22:1.
04.01.2021Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19)
04.01.2021Trials 2021; 22:1
Urwyler Pascal, Sendi Parham, Albrich Werner, Stüssi-Helbling Melina, Huber Lars C, Bacci Marcelo R, Camacho-Ortiz Adrián, Sumer Johannes, Thoma Reto, Trendelenburg Marten, Heijnen Ingmar A F M, Moser Stephan, Charitos Panteleimon, Osthoff Michael
Factors to Consider When Assessing the Diagnostic Accuracy of Synovial Leukocyte Count in Periprosthetic Joint Infection
Ottink K, Strahm C, Muller-Kobold A, Sendi P, Wouthuyzen-Bakker M. Factors to Consider When Assessing the Diagnostic Accuracy of Synovial Leukocyte Count in Periprosthetic Joint Infection. J Bone Jt Infect 2019; 4:167-173.
02.08.2019Factors to Consider When Assessing the Diagnostic Accuracy of Synovial Leukocyte Count in Periprosthetic Joint Infection
02.08.2019J Bone Jt Infect 2019; 4:167-173
Ottink Karsten D, Strahm Carol, Muller-Kobold Anneke, Sendi Parham, Wouthuyzen-Bakker Marjan
Osteoarticular and skin and soft-tissue infections caused by Streptococcus agalactiae in elderly patients are frequently associated with bacteremia.
Ruppen C, Notter J, Strahm C, Sonderegger B, Sendi P. Osteoarticular and skin and soft-tissue infections caused by Streptococcus agalactiae in elderly patients are frequently associated with bacteremia. Diagn Microbiol Infect Dis 2017; 90:55-57.
19.09.2017Osteoarticular and skin and soft-tissue infections caused by Streptococcus agalactiae in elderly patients are frequently associated with bacteremia.
19.09.2017Diagn Microbiol Infect Dis 2017; 90:55-57
Ruppen Corinne, Notter Julia, Strahm Carol, Sonderegger Beat, Sendi Parham
Brucella melitensis prosthetic joint infection
Flury D, Behrend H, Sendi P, von Kietzell M, Strahm C. Brucella melitensis prosthetic joint infection. J Bone Jt Infect 2017; 2:136-142.
05.04.2017Brucella melitensis prosthetic joint infection
05.04.2017J Bone Jt Infect 2017; 2:136-142
Flury Domenica, Behrend Henrik, Sendi Parham, von Kietzell Matthias, Strahm Carol